Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Roche Donates Over 5M Packs of Anti-Viral to WHO

By Pharmaceutical Processing | May 12, 2009

BASEL, Switzerland (AP) — Roche Holding AG said Tuesday it is donating 5.65 million packets of Tamiflu, one of two anti-viral drugs known to be effective against swine flu, to the World Health Organization. Roche said 5 million packets will be used to replenish stockpiles that were depleted when WHO sent previously donated supplies to poor countries after the appearance of a new type of swine flu, dubbed A(H1N1). A further 650,000 packets containing smaller doses of the drug will be used to create a new stockpile for children. Each packet of the drug is enough for one course of treatment. “The recent outbreak of influenza A (H1N1) shows that such a virus can be totally unexpected and spread rapidly around the globe,” the head of Roche’s pharmaceuticals division, William M. Burns, said. “This emphasizes the urgency of restoring WHO and Roche Rapid Response Stockpiles, alongside national government stockpiles, to prepare for subsequent waves with this virus or for addressing newly emerging influenza strains.” Roche said it can make 110 million packets over the next five months — or about 22 million a month — and increase production capacity to 36 million a month by the end of the year if there is sufficient demand. “This equates to a maximum annual capacity of 400 million treatment courses per year,” the company said. But with WHO estimating that up to 2 billion people could become infected with the disease over the next two years, some experts have questioned whether Roche should be allowed to dictate the production of Tamiflu in the event of a pandemic. The Basel-based company has licensed the drug to several other producers to make a generic version — known as oseltamivir — but there is no guarantee they and Roche would be able to produce enough doses if the virus spreads rapidly.

Related Articles Read More >

Wyzo
Wyzo high-speed pick-and-place sidebot wins design awards
Purdue University
Purdue University launches institute for advanced manufacturing of pharmaceuticals
Sanofi logo
Sanofi introduces its first digital accelerator 
Cambridge Pharma launches with UK plant in Cambridge Research Park

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards